Letrofil 2.5 mg Tablet

उत्पाद विवरण

Letrofil 2.5 mg tablet is an effective aromatase inhibitor specifically designed for the treatment of hormone receptor-positive breast cancer in postmenopausal women. By blocking the aromatase enzyme, Letrofil significantly reduces estrogen levels in the body, which is crucial since estrogen can fuel the growth of certain breast cancer cells. This medication not only helps in managing active breast cancer but also plays a vital role in preventing recurrence after initial treatment. Its essential for patients to discuss their complete medical history with their healthcare provider, as Letrofil may cause side effects like hot flashes, joint pain, or fatigue. Additionally, this medication should not be used in premenopausal women or those who are pregnant or breastfeeding. Regular monitoring by a healthcare professional is recommended to ensure safe and effective use. With Letrofil, patients can take a proactive step in their breast cancer management journey, working towards improved outcomes and enhanced quality of life. Always consult your doctor for personalized advice and to determine if Letrofil is the right option for your treatment plan.